Stable improvement of renal function after initiation of highly active anti-retroviral therapy in patients with HIV-1-associated nephropathy (original) (raw)

This report details the outcomes of three patients diagnosed with HIV-1-associated nephropathy (HIVAN) who experienced significant improvements in renal function following the initiation of highly active anti-retroviral therapy (HAART) and ACE-inhibition. The findings suggest that HAART combined with ACE-inhibition may be an optimal treatment strategy for HIVAN, emphasizing the importance of early intervention to prevent irreversible kidney damage. The data highlights the complexity of treatment for HIVAN and the necessity for careful monitoring of renal function in affected patients.